Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spident is a South Korea-based dental materials and medical device company focused on the development, manufacture, and commercialization of restorative, endodontic, adhesive, impression, temporary cement, whitening, and related dental products. Founded in 1997, the company operates its own R&D and manufacturing capabilities and markets products globally. Its portfolio includes composite resins, etchants, bonding agents, root canal materials, impression materials, temporary filling and cement products, and dental needles. Spident positions itself as a specialized biomedical and dental materials company rather than a therapeutics developer, with an emphasis on clinician-facing consumables and procedure-support products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spident.